Pharmacokinetics of intravenous gentamicin in healthy young-adult compared to aged alpacas.

Author: BedeniceD, CeresiaM, GestrichA, ZaghloulI

Paper Details 
Original Abstract of the Article :
The study objective was to evaluate the effects of age on aminoglycoside pharmacokinetics in eight young-adult (<4 years) and eight aged (≥14 years) healthy alpacas, receiving a single 6.6 mg/kg intravenous gentamicin injection. Heparinized plasma samples were obtained at des...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://pubmed.ncbi.nlm.nih.gov/29761517

データ提供:米国国立医学図書館(NLM)

Pharmacokinetics of Intravenous Gentamicin in Alpacas

This study investigates the pharmacokinetics of intravenous gentamicin in healthy young-adult and aged alpacas. The researchers administered a single 6.6 mg/kg intravenous gentamicin injection to eight young-adult alpacas (less than 4 years old) and eight aged alpacas (14 years or older). They then collected and analyzed plasma samples at designated time points to determine the drug's pharmacokinetic profile in both age groups. The study found that gentamicin clearance was significantly greater in young-adult alpacas compared to aged animals.

Gentamicin Pharmacokinetics in Alpacas

The study's findings indicate that gentamicin clearance is influenced by age in alpacas. Young-adult alpacas exhibited significantly higher gentamicin clearance compared to aged animals. This information is crucial for optimizing gentamicin dosing in alpacas, ensuring effective treatment while minimizing the risk of adverse drug reactions.

Optimizing Gentamicin Dosing

The research highlights the importance of considering age-related differences in drug pharmacokinetics when treating alpacas with gentamicin. The study's findings provide valuable insights for veterinarians to adjust gentamicin dosing based on age and ensure effective treatment outcomes.

Dr.Camel's Conclusion

Just as the desert landscape is shaped by the passage of time, so too is the body's response to medication influenced by age. This research provides valuable insights into the pharmacokinetics of gentamicin in alpacas, emphasizing the need for age-adjusted dosing strategies to optimize treatment outcomes. The findings underscore the importance of understanding the dynamic nature of drug metabolism and ensuring safe and effective treatment for our animal companions.

Date :
  1. Date Completed 2018-10-16
  2. Date Revised 2020-02-25
Further Info :

Pubmed ID

29761517

DOI: Digital Object Identifier

NIHMS1009721

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.